Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimization strategies aimed to increase the efficacy of H. pylori
eradication therapies
Authors
Keywords
-
Journal
HELICOBACTER
Volume 22, Issue 4, Pages e12392
Publisher
Wiley
Online
2017-05-03
DOI
10.1111/hel.12392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments ofHelicobacter pyloriinfection
- (2016) P.-Y. Chen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
- (2016) Carlo A. Fallone et al. GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole forHelicobacter pylorifirst-line treatment
- (2016) Ignasi Puig et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hybrid, sequential and concomitant therapies forHelicobacter pylorieradication: A systematic review and meta-analysis
- (2016) Zhi-Qiang Song et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication ofHelicobacter pylori: A Comparative Study in a Cohort of Romanian Patients
- (2016) Stefan Sorin Arama et al. Gastroenterology Research and Practice
- Optimised empiric triple and concomitant therapy forHelicobacter pylorieradication in clinical practice: the OPTRICON study
- (2015) J. Molina-Infante et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the global emergence ofHelicobacter pyloriantibiotic resistance
- (2015) I. Thung et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection
- (2015) Jyh-Chin Yang et al. Clinical Gastroenterology and Hepatology
- Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-lineHelicobacter pyloritherapy
- (2015) Wei Zhang et al. GUT
- Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
- (2015) Seong tae Lee et al. Gut and Liver
- Hp-normogram (normo-graham) for Assessing the Outcome ofH. pyloriTherapy: Effect of Resistance, Duration, and CYP2C19 Genotype
- (2015) David Y. Graham HELICOBACTER
- Meta-Analysis of Sequential, Concomitant and Hybrid Therapy for Helicobacter pylori Eradication
- (2015) Lei He et al. INTERNAL MEDICINE
- Hybridvssequential therapy for eradication ofHelicobacter pyloriin Taiwan: A prospective randomized trial
- (2015) Kuan-Yang Chen WORLD JOURNAL OF GASTROENTEROLOGY
- Hybrid therapy forHelicobacter pyloriinfection: A systemic review and meta-analysis
- (2015) Ping-I Hsu WORLD JOURNAL OF GASTROENTEROLOGY
- Comparative effectiveness and tolerance of treatments forHelicobacter pylori: systematic review and network meta-analysis
- (2015) Bao-Zhu Li et al. BMJ-British Medical Journal
- Comparative effectiveness and tolerance of treatments forHelicobacter pylori: systematic review and network meta-analysis
- (2015) Bao-Zhu Li et al. BMJ-British Medical Journal
- Improved Eradication Rate of Standard Triple Therapy by Adding Bismuth and Probiotic Supplement for Helicobacter pylori Treatment in Thailand
- (2015) Chanagune Srinarong et al. Asian Pacific Journal of Cancer Prevention
- 245 Effects of Different Dosing Schedules of Amoxicillin on the Eradication Rates of Helicobacter pylori by Triple Therapy With a Proton Pump Inhibitor, Amoxicillin, and Either Clarithromycin or Metronidazole
- (2015) Takahisa Furuta et al. GASTROENTEROLOGY
- Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication ofHelicobacter pylori
- (2014) J. C. Delchier et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review: Efficacy and Safety of Hybrid Therapy forHelicobacter pyloriInfection: A Systematic Review and Meta-analysis
- (2014) Ben Wang et al. HELICOBACTER
- Feasibility of Shortening 14-day Hybrid Therapy While Maintaining an ExcellentHelicobacter pyloriEradication Rate
- (2014) Jeng-Yih Wu et al. HELICOBACTER
- Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study
- (2014) V. De Francesco et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Optimizing clarithromycin-containing therapy forHelicobacter pyloriin the era of antibiotic resistance
- (2014) Javier Molina-Infante WORLD JOURNAL OF GASTROENTEROLOGY
- Treatment ofHelicobacter pyloriinfection: Current status and future concepts
- (2014) Jyh-Chin Yang WORLD JOURNAL OF GASTROENTEROLOGY
- Meta-analysis: Sequential Therapy Appears Superior to Standard Therapy for Helicobacter pylori Infection in Patients Naive to Treatment
- (2013) Nadim S. Jafri ANNALS OF INTERNAL MEDICINE
- Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study
- (2013) Xiao Liang et al. Clinical Gastroenterology and Hepatology
- Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
- (2013) David Y. Graham et al. Clinical Gastroenterology and Hepatology
- Sequential Therapy Versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication: a Systematic Review of Recent Evidence
- (2013) Vikram Kate et al. DRUGS
- Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance
- (2013) Javier Molina–Infante et al. GASTROENTEROLOGY
- The Efficacy of Two-Week Quadruple First-Line Therapy with Bismuth, Lansoprazole, Amoxicillin, Clarithromycin onHelicobacter pyloriEradication: A Prospective Study
- (2013) Bilal Ergül et al. HELICOBACTER
- The Effects of Multistrain Probiotic Compound on Bismuth-Containing Quadruple Therapy for Helicobacter pylori Infection: A Randomized Placebo-Controlled Triple-Blind Study
- (2013) Ahmad Shavakhi et al. HELICOBACTER
- Clinical Outcomes of Two-Week Sequential and Concomitant Therapies forHelicobacter pyloriEradication: A Randomized Pilot Study
- (2013) Ji Hyun Lim et al. HELICOBACTER
- Effect of Fluoroquinolone Resistance on 14-day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy
- (2013) Jingxian Liao et al. HELICOBACTER
- Effect of dosing schemes of amoxicillin on eradication rates ofHelicobacter pyloriwith amoxicillin-based triple therapy
- (2013) Takahisa Furuta et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of CYP2C19 Loss-of-Function Variants on the Eradication of H. pylori Infection in Patients Treated with Proton Pump Inhibitor-Based Triple Therapy Regimens: A Meta-Analysis of Randomized Clinical Trials
- (2013) Hui-Lin Tang et al. PLoS One
- Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
- (2013) L. Gatta et al. BMJ-British Medical Journal
- Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection
- (2012) A. G. McNicholl et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Meta-analysis: sequential therapy for Helicobacter pylori eradication in children
- (2012) A. Horvath et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Standard triple and sequential therapies for Helicobacter pylori eradication: An update
- (2012) Angelo Zullo et al. European Journal of Internal Medicine
- Which Therapy for Helicobacter pylori Infection?
- (2012) David Y. Graham et al. GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report
- (2012) Peter Malfertheiner et al. GUT
- Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption
- (2012) Francis Megraud et al. GUT
- Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin-Containing Triple Therapy provides a Good Cumulative Eradication Rate
- (2012) Marco Manfredi et al. HELICOBACTER
- Helicobacter pyloriEradication with Ecabet Sodium, Omeprazole, Amoxicillin, and Clarithromycin Versus Bismuth, Omeprazole, Amoxicillin, and Clarithromycin Quadruple Therapy: A Randomized, Open-Label, Phase IV Trial
- (2012) Jie Liang et al. HELICOBACTER
- The Efficacy of Second-Line Anti-Helicobacter pyloriTherapy Using an Extended 14-Day Levofloxacin/Amoxicillin/Proton-Pump Inhibitor Treatment - A Pilot Study
- (2012) Seng-Kee Chuah et al. HELICOBACTER
- Greater Than 95% Success with 14-day Bismuth Quadruple Anti-Helicobacter pyloriTherapy: A Pilot Study in US Hispanics
- (2012) Cesar O. Salazar et al. HELICOBACTER
- Pilot Studies to Identify the Optimum Duration of Concomitant Helicobacter pylori Eradication Therapy in Thailand
- (2012) Chutima Kongchayanun et al. HELICOBACTER
- Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection
- (2012) Javier P. Gisbert et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Comparative Study of Helicobacter pylori Eradication Rates With 5-day Quadruple “Concomitant” Therapy and 7-day Standard Triple Therapy
- (2012) Seung Young Kim et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Comparison of sequential and 7-, 10-, 14-d triple therapy forHelicobacter pyloriinfection
- (2012) Hyuk Soon Choi WORLD JOURNAL OF GASTROENTEROLOGY
- Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Second-line Helicobacter pylori Eradication: A Randomized Comparison of 1-week or 2-week Bismuth-containing Quadruple Therapy
- (2011) Jun-Won Chung et al. HELICOBACTER
- Efficacy of 2-Week, Second-Line Helicobacter pylori Eradication Therapy Using Rabeprazole, Amoxicillin, and Metronidazole for the Japanese Population
- (2011) Kazutoshi Hori et al. HELICOBACTER
- A New Modified Concomitant Therapy for Helicobacter pylori Eradication in Turkey
- (2011) Ahmet Burak Toros et al. HELICOBACTER
- 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial
- (2011) E Robert Greenberg et al. LANCET
- Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
- (2011) Peter Malfertheiner et al. LANCET
- Optimal therapy for Helicobacter pylori infections
- (2011) Emiko Rimbara et al. Nature Reviews Gastroenterology & Hepatology
- Helicobacter pylori Eradication Therapy Research: Ethical Issues and Description of Results
- (2010) David Y. Graham Clinical Gastroenterology and Hepatology
- Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection
- (2010) Takahisa Furuta et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Helicobacter pylori treatment in the era of increasing antibiotic resistance
- (2010) D. Y. Graham et al. GUT
- Bismuth-Containing Quadruple Therapy as Second-Line Treatment forHelicobacter pyloriInfection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea
- (2010) Byoung Hwan Lee et al. HELICOBACTER
- High Efficacy of 14-Day Triple Therapy-Based, Bismuth-Containing Quadruple Therapy for Initial Helicobacter pylori Eradication
- (2010) Qinjuan Sun et al. HELICOBACTER
- Bismuth improves PPI-based triple therapy for H. pylori eradication
- (2010) Peter Malfertheiner Nature Reviews Gastroenterology & Hepatology
- Helicobacter pyloriInfection
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
- (2010) Yuqin Li et al. WIENER KLINISCHE WOCHENSCHRIFT
- Sequential Therapy or Triple Therapy for Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults and Children
- (2009) Luigi Gatta et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Helicobacter pyloriEradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens
- (2009) Tajana Filipec Kanizaj et al. HELICOBACTER
- Meta-analysis: Four-Drug, Three-Antibiotic, Non-bismuth-Containing “Concomitant Therapy” Versus Triple Therapy forHelicobacter pyloriEradication
- (2009) Abdallah Said Essa et al. HELICOBACTER
- Editorial: H. pylori Treatment: New Wine in Old Bottles?
- (2008) Nimish Vakil AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficient Identification and Evaluation of Effective Helicobacter pylori Therapies
- (2008) David Y. Graham Clinical Gastroenterology and Hepatology
- Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication
- (2008) S. Di Caro et al. DIGESTIVE AND LIVER DISEASE
- ¿Son más eficaces dosis más elevadas de inhibidores de la bomba de protones para el tratamiento de la infección por Helicobacter pylori?
- (2008) Albert Villoria Gastroenterologia y Hepatologia
- Comparative Study ofHelicobacter pyloriEradication Rates of Twice-Versus Four-Times-Daily Amoxicillin Administered with Proton Pump lnhibitor and Clarithromycin: A Randomized Study
- (2008) Seung Young Kim et al. HELICOBACTER
- Effect of CYP2C19 Genetic Polymorphisms on the Efficacy of Proton Pump Inhibitor-Based Triple Therapy forHelicobacter pyloriEradication: A Meta-Analysis
- (2008) Fujun Zhao et al. HELICOBACTER
- Sequential therapy vs. standard triple therapies forHelicobacter pyloriinfection: a meta-analysis
- (2008) J. L. Tong et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Comparison of short- and long-term treatment protocols and the results of second-line quadruple therapy in children with Helicobacter pylori infection
- (2008) Yusuf Usta et al. JOURNAL OF GASTROENTEROLOGY
- Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis
- (2008) Alexander C Ford et al. WORLD JOURNAL OF GASTROENTEROLOGY
- “Rescue” regimens after Helicobacter pylori treatment failure
- (2008) Javier P Gisbert WORLD JOURNAL OF GASTROENTEROLOGY
- Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients
- (2007) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started